More stable pressure during induction is a short-term physiological finding rather than proof of superior overall surgical safety.
The randomized trial enrolled 150 coronary-bypass patients with ejection fractions at or below thirty-five percent. Diazepam, propofol and etomidate induction were compared using blood pressure and heart rate measured around laryngoscopy and intubation. The diazepam group had less marked pressure decreases and a different heart-rate response.
The endpoints covered a brief induction window. Premedication and weight-related dosing were acknowledged potential confounders. The results cannot establish reduced mortality, myocardial injury or prolonged recovery risk, and do not support a universal preferred agent for all cardiac patients.
For an anesthetic opinion, distinguish circulatory response immediately after induction from later cardiac output, ischemia and outcomes. Review the complete opioid, benzodiazepine and induction regimen. A comparative average does not establish that a particular patient’s pressure change was caused solely by the selected induction drug.
Source reviewed: Comparing Hemodynamic Responses to Diazepam Propofol and Etomidate During Anesthesia Induction in Pa (PMC5585810). Forensic applications above are interpretive analysis of the supplied publication.
Related reading: Etomidate–Midazolam Versus Propofol–Ketamine in Patients With Reduced Ejection Fraction.